ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

Genewiz from Azenta Life Sciences at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Genewiz from Azenta Life Sciences brings 2 presentations to ASHG 2026 in Montréal, and exhibits at Booth 1314. Its program at this meeting centres on gene-therapy vector performance and cell-free RNA biomarkers from liquid biopsy and urine. Its presentations examine inverted terminal repeats in AAV vectors for CNS gene therapy and detect RNA biomarkers in liquid biopsy and urine.

OrganizationASHG 2026 Attendance
Genewiz from Azenta Life Sciences
Burlington, Massachusetts
1 Senior Product Manager, Next Generation Sequencing · 1 other presenter
Subsidiary
GENEWIZ sells genomics and multiomics services, custom DNA synthesis, and gene-to-discovery workflows. It serves researchers and life-science organizations.
Azenta appointed Martin Madaus as interim CEO after John Marotta resigned, a leadership change at Genewiz's parent company.
›
Azenta appointed Martin Madaus as interim CEO after John Marotta resigned, a leadership change at Genewiz's parent company.
2026-08 · source
Azenta appointed Trey Martin president of its Multiomics business, a new leadership contact for Genewiz's genomics services.
2026-04 · source
Azenta completed its acquisition of UK Biocentre, expanding Genewiz's biorepository and sample-storage capabilities.
2026-03 · source
Source: company newsroom
Parent Azenta Q3 FY2026 revenue $161M, up 12%
›
FY2026 guidance for continuing operations is $613M-$618M, signaling continued growth. · 2026-08-04
“Revenue was $161million, up 12% year over year. total reported revenue from continuing operations to range approximately between $613 to $618 million”
Source: results release
Currently hiring: 55 open roles
›
Source: careers page
Booth
Exhibiting at Booth 1314
Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm
Poster
Wed Oct 21
2:30 pm
Exploring the Role of Inverted Terminal Repeats in AAV Vector Performance for CNS Gene Therapy
Gene therapyNeurodegenerationSequencing technologyBrain/nervous system
Poster
Fri Oct 23
2:30 pm
Cell-free RNA biomarker detection from liquid biopsy and urine
Clinical testingPrecision medicineTranslational studies and preclinical trialsRNA

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Genewiz from Azenta Life Sciences

Tell us what you sell and we’ll find the people at Genewiz from Azenta Life Sciences most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction